Results 21 to 30 of about 27,566 (147)

Şizofrenide ilaç sağaltımı

Psychiatry and Clinical Psychopharmacology, 2021
Pharmacotheraphy in schizophrenia begins with the discovery of chlorpromazine. Later the synthesis of other various antipsychotics has led psychotic patients to get out of hospitals and live in the society.
Leyla Gülseren, Almıla Erol
doaj  

Antipsychotics and Risks of Cardiovascular and Cerebrovascular Diseases and Mortality in Dwelling Community Older Adults

Pharmaceuticals
This study aims to investigate the effect of antipsychotic agents on cardiovascular and cerebrovascular diseases (CVD/CEV) and mortality risks in the older population living in a community.
Sylvie Perreault, Laurie-Anne Boivin Proulx, Judith Brouillette, Stéphanie Jarry, Marc Dorais   +4 more
doaj   +1 more source

Association Between Antipsychotic Treatment and Neurological Adverse Events in Pediatric Patients: A Population-Based Cohort Study in Korea

Frontiers in Psychiatry, 2021
Background: Potential adverse effects might be caused by increasing the number of antipsychotic prescriptions. However, the empirical evidence regarding pediatric psychiatric patients is insufficient.
Soo Min Jeon, Susan Park, Soonhak Kwon, Jin-Won Kwon   +3 more
doaj   +1 more source

Sertindole in the Management of Schizophrenia

Journal of Central Nervous System Disease, 2011
Nowadays, new schizophrenia treatments are more ambitious than ever, aiming not only to improve psychotic symptoms, but also quality of life and social reinsertion.
Mario F. Juruena, Eduardo Ponde00C9; De Sena, Irismar Reis De Oliveira   +2 more
doaj   +1 more source

HOW ASSESS DRUGS IN THE TREATMENT OF ACUTE BIPOLAR MANIA ?

Frontiers in Pharmacology, 2013
Bipolar affective disorder is a serious mental disease associated with significant morbidity and mortality. Good-quality research available to guide treatment strategies remains insufficient, particularly with regard to manic or hypomanic episodes.
Michel eBourin, Florence eThibaut
doaj   +1 more source

Identifying dopamine supersensitivity through a randomized controlled study of switching to aripiprazole from other antipsychotic agents in patients with schizophrenia

Therapeutic Advances in Psychopharmacology, 2022
Background: Aripiprazole has been reported to worsen psychotic symptoms when switching from other antipsychotics, possibly due to dopamine supersensitivity psychosis.
Chia-Hao Ma, Hung-Yu Chan, Ming H. Hsieh, Chen-Chung Liu, Chih-Min Liu, Hai-Gwo Hwu, Ching-Hua Kuo, Wei J. Chen, Tzung-Jeng Hwang   +8 more
doaj   +1 more source

Pharmaceutical-Induced Dyskinesia: A Case Study of Thoracotomy Treated with Amantadine

Case Reports in Clinical Practice
Dyskinesia, marked by involuntary and irregular movements, can result from various pharmaceutical agents. The case presented features a patient undergoing thoracotomy, experiencing dyskinesia, likely attributed to antipsychotics, antiemetics, and ...
Mojtaba Mojtahedzadeh, Atabak Najafi, Farahnaz Hosseinzadeh, Fatemeh Saghafi   +3 more
doaj   +1 more source

Current perspectives on the epidemiology and burden of tardive dyskinesia: a focused review of the clinical situation in Japan

Therapeutic Advances in Psychopharmacology, 2022
Tardive dyskinesia (TD) is a movement disorder that can develop with the use of dopamine receptor-blocking agents and is most commonly caused by antipsychotics.
Yasuhiro Mori, Hiroyoshi Takeuchi, Yuichiro Tsutsumi   +2 more
doaj   +1 more source

Serotonin Syndrome Triggered by Increasing the Dose of Quetiapine

Clinical Practice and Cases in Emergency Medicine, 2021
Case presentation: An 85-year-old woman with a history of depression treated with polypharmacy including selective serotonin reuptake inhibitor presented to the emergency department with head, and upper and lower limb tremors four hours after increasing ...
Yayoi Miyamatsu, Ryutaro Tanizaki
doaj   +1 more source

Antipsychotics in the Treatment of Children and Adolescents with Anorexia Nervosa: A Systematic Review

Biomedicines, 2022
Evidence about the use of pharmacologic agents in the treatment of Anorexia Nervosa (AN) is lacking, especially in childhood and adolescence. A systematic scoping review was conducted to outline current literature evidence about the use of antipsychotics
Jacopo Pruccoli, Luca Bergonzini, Angela La Tempa, Antonia Parmeggiani   +3 more
doaj   +1 more source